Aripiprazole Metabolite

Aripiprazole Metabolite Struktur
58899-27-7
CAS-Nr.
58899-27-7
Englisch Name:
Aripiprazole Metabolite
Synonyma:
Aripiprazole Metabolite;Aripiprazole impurities1756;Aripiprazole Butanoic Acid Impurity;3,4-Dihydro-7-(3’carboxy)propoxy-2(1H)-quinolinone;3,4-Dihydro-7-(3a€carboxy)propoxy-2(1H)-quinolinone;4-[(2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy]butanoic acid;4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]-butanoic acid;Butanoic acid, 4-[(1,2,3,4-tetrahydro-2-oxo-7-quinolinyl)oxy]-
CBNumber:
CB42706614
Summenformel:
C13H15NO4
Molgewicht:
249.26
MOL-Datei:
58899-27-7.mol

Aripiprazole Metabolite Eigenschaften

Schmelzpunkt:
216-218°C
Siedepunkt:
533.8±50.0 °C(Predicted)
Dichte
1.265±0.06 g/cm3(Predicted)
storage temp. 
Refrigerator
Löslichkeit
DMSO (Slightly, Heated), Methanol (Slightly, Heated)
Aggregatzustand
Solid
pka
4.59±0.10(Predicted)
Farbe
White to Off-White

Sicherheit

Aripiprazole Metabolite Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

3,4-Dihydro-7-(3’carboxy)propoxy-2(1H)-quinolinone is a metabolite of Aripiprazole (A771000); a selective dopamine D2-receptor antagonist with dopamine autoreceptor agonist activity. Also an antipsychotic. Aripiprazole Butanoic Acid Impurity

Aripiprazole Metabolite Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Aripiprazole Metabolite Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 29)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
CR Corporation Lomited

fred.wen@crcorporation.cn CHINA 12069 58
sgtlifesciences pvt ltd
+8617013299288
dj@sgtlifesciences.com China 12382 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Nanjing XiZe Biotechnology CO., Ltd. 025-58362220 15250997978
1511893459@qq.com China 7726 55
Shanghai Xiang Xin Industrial Co., Ltd. 021-50211651 13651607026
sales@xxgmpharm.com China 494 58
BOC Sciences 16314854226
info@bocsci.com United States 9926 65
Tonichem Pharmaceutical Technology Co., Ltd. +86 (0752) 222-7171, +86 15815821171
China 1120 58
Shanghai CR Corporation Limited 4006653949
fred.wen@crcorporation.cn China 10112 58
Shenzhen SUNGENING Bio-Medical Co., Ltd. 0755-28967200 13631290199
wxf@sungening.com China 9507 60
Guangzhou Dreampharm Biotechnology Co., Ltd. 17825480238
3008233717@qq.com China 9843 12

58899-27-7()Verwandte Suche:


  • Aripiprazole Metabolite
  • Aripiprazole Butanoic Acid Impurity
  • 3,4-Dihydro-7-(3a€carboxy)propoxy-2(1H)-quinolinone
  • 4-[(2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy]butanoic acid
  • 3,4-Dihydro-7-(3’carboxy)propoxy-2(1H)-quinolinone
  • 4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]-butanoic acid
  • Butanoic acid, 4-[(1,2,3,4-tetrahydro-2-oxo-7-quinolinyl)oxy]-
  • Aripiprazole impurities1756
  • 58899-27-7
Copyright 2019 © ChemicalBook. All rights reserved